Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Emin Kuliyev is active.

Publication


Featured researches published by Emin Kuliyev.


Development | 2005

BMP4-dependent expression of Xenopus Grainyhead-like 1 is essential for epidermal differentiation.

Jianning Tao; Emin Kuliyev; Xi Wang; Xiuling Li; Tomasz Wilanowski; Stephen M. Jane; Paul E. Mead; John M. Cunningham

Morphogen-dependent epidermal-specific transacting factors have not been defined in vertebrates. We demonstrate that a member of the grainyhead transcription factor family, Grainyhead-like 1 (XGrhl1) is essential for ectodermal ontogeny in Xenopus laevis. Expression of this factor is restricted to epidermal cells. Moreover, XGrhl1 is regulated by the BMP4 signaling cascade. Disruption of XGrhl1 activity in vivo results in a severe defect in terminal epidermal differentiation, with inhibition of XK81A1 epidermal keratin gene expression, a key target of BMP4 signaling. Furthermore, transcription of the XK81A1 gene is modulated directly by binding of XGRHL1 to a promoter-localized binding motif that is essential for high-level expression. These results establish a novel developmental role for XGrhl1 as a crucial tissue-specific regulator of vertebrate epidermal differentiation.


Developmental Dynamics | 2007

A flk-1 promoter/enhancer reporter transgenic Xenopus laevis generated using the Sleeping Beauty transposon system: an in vivo model for vascular studies.

Joanne R. Doherty; Michelle R. Johnson Hamlet; Emin Kuliyev; Paul E. Mead

We have used the Sleeping Beauty (SB) transposable element to generate transgenic Xenopus laevis with expression of green fluorescent protein (GFP) in vascular endothelial cells using the frog flk‐1 promoter. This is the first characterization of a SB‐generated transgenic Xenopus that has tissue‐restricted expression. We demonstrate that the transgene integrated into single genomic loci in two independent founder lines and is transmitted through the germline at the expected Mendelian frequencies. Transgene integration occurred through a noncanonical transposition process possibly reflecting Xenopus‐specific interactions with the SB system. The transgenic animals express GFP in the same spatial and temporal pattern as the endogenous flk‐1 gene throughout development and into adulthood. Overexpression of xVEGF122 in the transgenic animals disrupts vascular development that is visualized by fluorescent microscopy. These studies demonstrate the convenience of the SB system for generating transgenic animals and the utility of the xflk‐1:GFP transgenic line for in vivo studies of vascular development. Developmental Dynamics 236:2808–2817, 2007.


Developmental Dynamics | 2009

Transgenesis in Xenopus using the Sleeping Beauty transposon system.

Donald Yergeau; Michelle R. Johnson Hamlet; Emin Kuliyev; Haiqing Zhu; Joanne R. Doherty; Taylor D. Archer; Andrea P. Subhawong; Marc Valentine; Clair M. Kelley; Paul E. Mead

Transposon‐based integration systems have been widely used for genetic manipulation of invertebrate and plant model systems. In the past decade, these powerful tools have begun to be used in vertebrates for transgenesis, insertional mutagenesis, and gene therapy applications. Sleeping Beauty (SB) is a member of Tc1/mariner class of transposases and is derived from an inactive form of the gene isolated from Atlantic salmon. SB has been used extensively in human cell lines and in whole animal vertebrate model systems such as the mouse, rat, and zebrafish. In this study, we describe the use of SB in the diploid frog Xenopus tropicalis to generate stable transgenic lines. SB transposon transgenes integrate into the X. tropicalis genome by a noncanonical process and are passed through the germline. We compare the activity of SB in this model organism with that of Tol2, a hAT (hobo, Ac1, TAM)‐like transposon system. Developmental Dynamics 238:1727–1743, 2009.


Developmental Dynamics | 2009

CDK9/cyclin complexes modulate endoderm induction by direct interaction with Mix.3/mixer

Haiqing Zhu; Joanne R. Doherty; Emin Kuliyev; Paul E. Mead

Mix‐related homeodomain proteins are involved in endoderm formation in the early vertebrate embryo. We used a yeast two‐hybrid screen to identify proteins that interact with Mix.3/mixer to regulate endoderm induction. We demonstrate that cyclin‐dependent kinase 9 (CDK9) interacts with the carboxyl terminal domain of Mix.3. CDK9 is the catalytic subunit of the PTEF‐b transcription elongation complex that phosphorylates the C‐terminal domain of RNA polymerase II to promote efficient elongation of nascent transcripts. Using whole embryo transcription reporter and animal pole explant assays, we show that Mix.3 activity is regulated by CDK9/cyclin complexes. Co‐expression of cyclin T2 and cyclin K had different effects on Mix.3 transcriptional activity and endoderm induction. Our data suggest that binding of CDK9, and the recruitment of different cyclin partners, can modulate the endoderm‐inducing activity of Mix.3 during embryonic development. Developmental Dynamics 238:1346–1357, 2009.


Methods | 2010

Transposon transgenesis in Xenopus

Donald Yergeau; Clair M. Kelley; Haiqing Zhu; Emin Kuliyev; Paul E. Mead

Transposon-mediated integration strategies in Xenopus offer simple and robust methods for the generation of germline transgenic animals. Co-injection of fertilized one-cell embryos with plasmid DNA harboring a transposon transgene and synthetic mRNA encoding the cognate transposase enzyme results in mosaic integration of the transposon at early cleavage stages that are frequently passed through the germline in the adult animal. Micro-injection of fertilized embryos is a routine procedure used by many laboratories that use Xenopus as a developmental model and, as such, the transposon transgenesis method can be performed without additional equipment or specialized methodologies. The methods for injecting Xenopus embryos are well documented in the literature so here we provide a step-by-step guide to other aspects of transposon transgenesis, including screening mosaic founders for germline transmission of the transgene and general husbandry considerations related to management of populations of transgenic frogs.


Mechanisms of Development | 2006

Determination of the minimal domains of Mix.3/Mixer required for endoderm development

Joanne R. Doherty; Haiqing Zhu; Emin Kuliyev; Paul E. Mead

The Mix/Bix family of Pax-like homeodomain transcription factors is expressed early in vertebrate development and play important roles in endoderm and mesoderm formation. Like other Pax-related homeodomain proteins, the Mix/Bix family binds DNA as monomers or dimers and dimerization is mediated by the homeodomain. While the Mix/Bix family shares extensive sequence homology within the DNA-binding homeodomain, ectopic expression of these proteins has profoundly different outcomes. Expression of Xenopus Mix.3/Mixer in explanted ectoderm results in endoderm differentiation, whereas Mix.1 expression does not. In this study we sought to define the domains of Mix.3/Mixer that are responsible for this endoderm inducing activity. We generated domain swap mutants between Mix.3/Mixer and Mix.1 and tested their ability to induce endoderm in explanted ectoderm. We demonstrate that the homeodomain and sixty-two amino acids in the carboxyl terminus are required to induce endoderm and that these domains must be on the same polypeptide and can not act in trans as a heterodimer. A Smad2 interaction motif in Mix.3/Mixer is involved in endoderm differentiation but is not essential. Thus, we have defined the regions of Mix.3/Mixer that confer endoderm-inducing activity. These studies reveal a novel co-operation between the homeodomain and a small domain in the carboxyl terminal region that is essential for Mix.3/Mixer function.


Developmental Dynamics | 2005

Expression of Xenopus suppressor of cytokine signaling 3 (xSOCS3) is induced by epithelial wounding.

Emin Kuliyev; Joanne R. Doherty; Paul E. Mead

The suppressor of cytokine signaling (SOCS) family of proteins are intracellular mediators of cytokine signaling. These proteins are induced rapidly by cytokine stimulation and act in a classic negative‐feedback loop to attenuate the cellular response to the cytokine signal. In this study, we present the cloning and initial characterization of the Xenopus SOCS3 gene. We show that xSOCS3 is rapidly induced in response to epithelial wounding in the tadpole. The induction of xSOCS3 in response to trauma is transient with maximal expression being reached 1 hr after the injury and diminishing after that. Unlike other genes known to be responsive to wound‐induced activation of the mitogen‐activated protein (MAP) kinase pathway, such as Egr1, SOCS3 expression in response to trauma is unaffected by blockade of the MAP kinase pathway by chemical inhibitors. Developmental Dynamics 233:1123–1130, 2005.


Cell & developmental biology | 2014

Embryonic Expression and Function of the Xenopus Ink4d Cyclin D-Dependent Kinase Inhibitor.

Joanne R. Doherty; Lisa M. Nilsson; Emin Kuliyev; Haiqing Zhu; Rose Matthew; John L. Cleveland; Paul E. Mead; Martine F. Roussel

Here we report the cloning and functional characterization of the cyclin D-dependent kinase 4 and 6 (Cdk4/6) inhibitory protein Cdkn2d/p19Ink4d of Xenopuslaevis (Xl-Ink4d). Xl-Ink4d is the only Ink4 family gene highly expressed during Xenopus development and its transcripts were detected maternally and during neurulation. The Xl-Ink4d protein has 63% identity to mouse and human Cdkn2d/p19Ink4d and its function as a negative regulator of cell cycle traverse is evolutionary conserved. Indeed, Xl-lnk4d can functionally substitute for mouse Cdkn2d in binding to mouse Cdk4 and inhibiting cyclin-D1-dependent CDK4 kinase activity. Further, enforced expression of Xl-lnk4d arrests mouse fibroblasts in the G1 phase of the cell cycle. These findings indicate that CDKN2d/p19Ink4d is conserved through vertebrate evolution and suggest Xl-lnk4d may contribute to the development of Xenopuslaevis.


PLOS ONE | 2017

SCYL1 does not regulate REST expression and turnover

Sebastien Gingras; Emin Kuliyev; Stephane Pelletier

A recent study identified SCYL1 as one of the components of the oncogenic STP axis, which promotes triple-negative breast cancer by regulating degradation of the REST tumor suppressor. Contrary to the findings of that study, herein we show by using 3 distinct genetic approaches that SCYL1 does not regulate REST turnover. Specifically, REST protein levels and turnover were identical in Scyl1+/+ and Scyl1-/- mouse embryonic fibroblasts. Similarly, targeted inactivation of SCYL1 in Hek293T cells by using CRIPSR-Cas9 technology did not affect REST steady-state level and turnover. Furthermore, RNA interference–mediated depletion of SCYL1 in Hek293T or MDA-MB-231 cells did not alter REST steady-state level and turnover. Together, our findings indicate that SCYL1 does not contribute to REST turnover and thus do not support a previous study suggesting a role for SCYL1 in mediating REST degradation.


Neoplasia | 2016

Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation

Yiannis Drosos; Geoffrey Neale; Jianming Ye; Leena Paul; Emin Kuliyev; Anirban Maitra; Anna L. Means; M. Kay Washington; Jerold E. Rehg; David B. Finkelstein; Beatriz Sosa-Pineda

The current paradigm of pancreatic neoplastic transformation proposes an initial step whereby acinar cells convert into acinar-to-ductal metaplasias, followed by progression of these lesions into neoplasias under sustained oncogenic activity and inflammation. Understanding the molecular mechanisms driving these processes is crucial to the early diagnostic and prevention of pancreatic cancer. Emerging evidence indicates that transcription factors that control exocrine pancreatic development could have either, protective or facilitating roles in the formation of preneoplasias and neoplasias in the pancreas. We previously identified that the homeodomain transcription factor Prox1 is a novel regulator of mouse exocrine pancreas development. Here we investigated whether Prox1 function participates in early neoplastic transformation using in vivo, in vitro and in silico approaches. We found that Prox1 expression is transiently re-activated in acinar cells undergoing dedifferentiation and acinar-to-ductal metaplastic conversion. In contrast, Prox1 expression is largely absent in neoplasias and tumors in the pancreas of mice and humans. We also uncovered that Prox1-heterozygosis markedly increases the formation of acinar-to-ductal-metaplasias and early neoplasias, and enhances features associated with inflammation, in mouse pancreatic tissues expressing oncogenic Kras. Furthermore, we discovered that Prox1-heterozygosis increases tissue damage and delays recovery from inflammation in pancreata of mice injected with caerulein. These results are the first demonstration that Prox1 activity protects pancreatic cells from acute tissue damage and early neoplastic transformation. Additional data in our study indicate that this novel role of Prox1 involves suppression of pathways associated with inflammatory responses and cell invasiveness.

Collaboration


Dive into the Emin Kuliyev's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Donald Yergeau

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar

Haiqing Zhu

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar

Joanne R. Doherty

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar

Clair M. Kelley

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar

Michelle R. Johnson Hamlet

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar

Beatriz Sosa-Pineda

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar

Yiannis Drosos

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna L. Means

Vanderbilt University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge